4.7 Letter

Race to Report: Are Vascular Endothelial Growth Factor Genetic Polymorphisms Associated With Outcome in Advanced Breast Cancer Patients Treated With Paclitaxel Plus Bevacizumab? REPLY

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 8, Pages 1342-1343

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2008.20.7175

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available